Danaher Co. (NYSE:DHR) Shares Purchased by Journey Strategic Wealth LLC

Journey Strategic Wealth LLC raised its holdings in Danaher Co. (NYSE:DHR) by 42.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,963 shares of the conglomerate’s stock after buying an additional 890 shares during the period. Journey Strategic Wealth LLC’s holdings in Danaher were worth $680,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. AMF Tjanstepension AB acquired a new position in Danaher in the third quarter valued at $5,923,000. Czech National Bank boosted its position in shares of Danaher by 4.2% in the 3rd quarter. Czech National Bank now owns 130,939 shares of the conglomerate’s stock valued at $36,404,000 after purchasing an additional 5,320 shares during the period. GAMMA Investing LLC grew its stake in Danaher by 33.5% during the 3rd quarter. GAMMA Investing LLC now owns 4,480 shares of the conglomerate’s stock worth $1,246,000 after buying an additional 1,125 shares during the last quarter. WealthBridge Capital Management LLC increased its position in Danaher by 51.8% during the third quarter. WealthBridge Capital Management LLC now owns 1,465 shares of the conglomerate’s stock worth $407,000 after buying an additional 500 shares during the period. Finally, Diversified Trust Co lifted its stake in Danaher by 29.6% in the third quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock valued at $1,571,000 after buying an additional 1,289 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on DHR shares. Jefferies Financial Group lowered their target price on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. UBS Group dropped their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. JPMorgan Chase & Co. decreased their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Raymond James dropped their price target on Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 21st. Finally, Barclays decreased their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday. Six investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $222.56 on Monday. The stock has a fifty day moving average price of $235.40 and a 200 day moving average price of $253.08. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a market cap of $160.75 billion, a PE ratio of 42.15, a P/E/G ratio of 4.22 and a beta of 0.83. Danaher Co. has a 1 year low of $221.34 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.72% and a net margin of 16.33%. During the same quarter in the prior year, the firm posted $2.09 earnings per share. Sell-side analysts forecast that Danaher Co. will post 8.15 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were paid a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.49%. Danaher’s dividend payout ratio (DPR) is 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.